JB Chemicals & Pharmaceuticals reported a 19% year-on-year increase in net profit to Rs 208 crore for the second quarter ended September 30, 2025. Revenue from operations rose to Rs 1,085 crore, driven by a strong performance in its domestic formulations business. International business also contributed to the growth, with revenue up 7%.